Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes
Franco Cosmi, Li Shen, Michela Magnoli, et al.
European Journal of Heart Failure (2018) Vol. 20, Iss. 5, pp. 888-895
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
European Heart Journal (2021) Vol. 42, Iss. 36, pp. 3599-3726
Open Access | Times Cited: 8643
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa McDonagh, Marco Metra, Marianna Adamo, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 1, pp. 4-131
Open Access | Times Cited: 1501
Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
Yi Tan, Zhiguo Zhang, Chao Zheng, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 9, pp. 585-607
Open Access | Times Cited: 548
Highlights in heart failure
Daniela Tomasoni, Marianna Adamo, Carlo Lombardi, et al.
ESC Heart Failure (2019) Vol. 6, Iss. 6, pp. 1105-1127
Open Access | Times Cited: 212
European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure
Petar Seferović, Andrew J.S. Coats, Piotr Ponikowski, et al.
European Journal of Heart Failure (2019) Vol. 22, Iss. 2, pp. 196-213
Open Access | Times Cited: 155
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA
Darren K. McGuire, John H. Alexander, Odd Erik Johansen, et al.
Circulation (2019) Vol. 139, Iss. 3, pp. 351-361
Open Access | Times Cited: 147
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure
Shruti Joshi, Trisha Singh, David E. Newby, et al.
Heart (2021) Vol. 107, Iss. 13, pp. 1032-1038
Open Access | Times Cited: 136
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
Revista Española de Cardiología (2022) Vol. 75, Iss. 6, pp. 523.e1-523.e114
Closed Access | Times Cited: 89
Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy
Isabella Evangelista, Ranuccio Nuti, Tommaso Picchioni, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3264-3264
Open Access | Times Cited: 125
New insights into the pathogenesis and treatment of sarcopenia in chronic heart failure
Jiayu Yin, Xiang Lü, Zhiyuan Qian, et al.
Theranostics (2019) Vol. 9, Iss. 14, pp. 4019-4029
Open Access | Times Cited: 115
SGLT2-inhibitors; more than just glycosuria and diuresis
Amir Fathi, Keeran Vickneson, Jagdeep Singh
Heart Failure Reviews (2020) Vol. 26, Iss. 3, pp. 623-642
Open Access | Times Cited: 80
Differential Pathophysiological Mechanisms in Heart Failure With a Reduced or Preserved Ejection Fraction in Diabetes
Milton Packer
JACC Heart Failure (2021) Vol. 9, Iss. 8, pp. 535-549
Open Access | Times Cited: 76
Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities
Zhiwei Li, Hongmei Zhao, Jing Wang
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 59
Treatment of type 2 diabetes patients with heart conditions
Gülali Aktaş, Burçin Meryem Atak Tel, Ramiz Tel, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 3, pp. 255-265
Closed Access | Times Cited: 31
Heart failure in the last year: progress and perspective
Daniela Tomasoni, Marianna Adamo, Markus S. Anker, et al.
ESC Heart Failure (2020) Vol. 7, Iss. 6, pp. 3505-3530
Open Access | Times Cited: 68
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
Li Shen, Rasmus Rørth, Deborah Cosmi, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 8, pp. 974-984
Open Access | Times Cited: 61
Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction
Alice M. Jackson, Rasmus Rørth, Jiankang Liu, et al.
European Journal of Heart Failure (2021) Vol. 24, Iss. 3, pp. 497-509
Open Access | Times Cited: 54
The sodium‐glucose co‐transporter‐2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosis
Julia Moellmann, Pascal Alexander Mann, Ben A. Kappel, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 11, pp. 2263-2272
Open Access | Times Cited: 32
2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care
Samuel Seidu, Xavier Cos, Stephen Brunton, et al.
Primary care diabetes (2022) Vol. 16, Iss. 2, pp. 223-244
Open Access | Times Cited: 30
Pleiotropic effects of SGLT2 inhibitors and heart failure outcomes
Panagiotis Theofilis, Μarios Sagris, Evangelos Oikonomou, et al.
Diabetes Research and Clinical Practice (2022) Vol. 188, pp. 109927-109927
Closed Access | Times Cited: 29
LncRNA ZNF593-AS alleviates diabetic cardiomyopathy via suppressing IRF3 signaling pathway
Rong Xie, Jiahui Fan, Jianpei Wen, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 689-703
Open Access | Times Cited: 16
Trends in Readmission and Mortality Rates Following Heart Failure Hospitalization in the Veterans Affairs Health Care System From 2007 to 2017
Justin Parizo, Shun Kohsaka, Alexander T. Sandhu, et al.
JAMA Cardiology (2020) Vol. 5, Iss. 9, pp. 1042-1042
Open Access | Times Cited: 39
Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD
João Pedro Ferreira, Francisco Vasques‐Nóvoa, Diana Ferrão, et al.
Diabetes Care (2022) Vol. 45, Iss. 7, pp. 1584-1591
Open Access | Times Cited: 22
Biological basis and treatment of frailty and sarcopenia
Ryosuke Sato, Mirela Vatic, Guilherme Wesley Peixoto da Fonseca, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 9, pp. 982-998
Open Access | Times Cited: 5
Advances in incretin therapies for targeting cardiovascular disease in diabetes
Theresa L. Roberts, Dana S. Hutchinson, Denise Wootten, et al.
Journal of Molecular and Cellular Cardiology (2025)
Closed Access
Page 1 - Next Page

Scroll to top